ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "informatics"

  • Abstract Number: 0373 • ACR Convergence 2021

    Self-monitoring of Disease Activity with a Smartphone App Is Feasible in Routine Clinical Management of Patients with Axial Spondyloarthritis – a Proof of Concept Study

    Uta Kiltz1, Robin Kempin1, Jutta Richter2, Anna Schlegel1, Xenofon Baraliakos1, Styliani Tsiami1, Bjoern Buehring1, David Kiefer3 and Juergen Braun1, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 2Rheumatology and Hiller Research Unit, Heinrich-Heine-University Duesseldorf, Medical Faculty, Duesseldorf, Germany, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Essen, Germany

    Background/Purpose: Assessment and monitoring of disease activity and functioning is of major importance for qualified management of patients with axial spondyloarthritis (axSpA). This includes tight…
  • Abstract Number: 0442 • ACR Convergence 2021

    Identification of Plexin D1 on Circulating Extracellular Vesicles as a Potential Biomarker of Polymyositis and Dermatomyositis

    Kenichi Uto1, Koji Ueda2, Takaichi Okano1, Kengo Akashi1, Soshi Takahashi3, Yuji Nakamachi4, Takamitsu Imanishi1, Seiji Kawano1, Yoshihiko Yano5 and Jun Saegusa6, 1Kobe University Hospital, Kobe, Japan, 2Japanese Foundation for Cancer Research, Tokyo, Japan, 3Shinko Hospital, Kobe, Japan, 4Kobe University School of Medicine, Kobe, Japan, 5Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan, 6Rheumatology and Clinical Immunology, Kobe University Hospital, Kobe, Japan

    Background/Purpose: Extracellular vesicles (EVs), including exosomes and microvesicles, are small membrane vesicles released by almost all cell types and are found circulating in blood and…
  • Abstract Number: 0561 • ACR Convergence 2021

    Enhancing the Identification of Rheumatoid Arthritis-Associated Interstitial Lung Disease in Electronic Health Records Through Text Mining of Computerized Tomography Reports

    Brent Luedders1, Brendan Cope2, Matt Devries2, W. Scott Campbell2, James Campbell2, Ted Mikuls3, Jeffrey Curtis4, Daniel Hershberger3 and Bryant England3, 1University of Nebraska Medical Center, Omaha, NE, United Kingdom, 2University of Nebraska Medical Center, Omaha, 3University of Nebraska Medical Center, Omaha, NE, 4Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Interstitial lung disease (ILD) is an extraarticular manifestation of RA that leads to increased morbidity and mortality. Algorithms incorporating multiple diagnostic and procedure codes…
  • Abstract Number: 0566 • ACR Convergence 2021

    Natural Language Processing of Electronic Health Record Notes Captures Forced Vital Capacity in Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Punyasha Roul1, Yangyuna Yang1, Daniel Hershberger1, Ted Mikuls1, Jorge Rojas2, Jeffrey Curtis3, Joshua Baker4, Brian Sauer5 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2VA Puget Sound, Seattle, WA, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 4University of Pennsylvania, Philadelphia, PA, 5University of Utah, Salt Lake City, UT

    Background/Purpose: Rheumatoid arthritis-interstitial lung disease (RA-ILD) has a poor long-term prognosis, including premature mortality. Longitudinal monitoring of patients in clinical and clinical trial settings includes…
  • Abstract Number: 0676 • ACR Convergence 2021

    Development, Refinement, and Validation of an Emergency Department Gout Flare Electronic Medical Record Alert

    Lesley Jackson1, Narender Annapureddy2, Kenneth Saag1, James Booth3, Giovanna Rosas1, Jeffrey Foster1, Amy Mudano1, Dongmei Sun4, John Osborne1, Tim Bongartz5, Erik Hess5, Colleen Lawrence6, Leah Dunkel6 and Maria I. Danila1, 1University of Alabama at Birmingham, Birmingham, AL, 2Vanderbilt University Medical Center, Nashville, TN, 3Department of Emergency Medicine, University of Alabama School of Medicine, Birmingham, AL, 4Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, AL, 5Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, TN, 6Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Patients with acute gout are frequently treated in emergency departments (ED) and represent a typically underserved and understudied population. A key limitation of conducting…
  • Abstract Number: 0982 • ACR Convergence 2021

    B Cells Repertoire Repartition Predicts Response to Methotrexate at 6 and 12 Months in Naïve RA: A Machine Learning Driven Approach

    Aurelie Najm1, Shrutii Sarda2, Michelle Toro3, Loni Pickle3, Stephanie Ostresh3, Fraser Morton4, Geoffrey Lowman3, Andrew Felton5 and Carl Goodyear4, 1Institute of Infection, Immunity and Inflammation, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 2Clinical Sequencing Division, Specialty Diagnostics Group, Thermo Fisher Scientific, South San Francisco-CA, United States, San Francisco, 3Clinical Sequencing Division, Specialty Diagnostics Group, Thermo Fisher Scientific, Carlsbad, CA, 4University of Glasgow, Glasgow, United Kingdom, 5VP, Platforms, Research & Applied, Specialty Diagnostics Group, South San Francisco, CA

    Background/Purpose: The adaptive immune system plays a central role in Rheumatoid Arthritis (RA) pathogenesis. Moreover, the composition of the B cell repertoire and its perturbation…
  • Abstract Number: 1069 • ACR Convergence 2021

    Supporting Patient-Centered Care in the Pediatric Rheumatology Setting: Patient, Family and Provider Experiences with OurNotes

    Uptej Khalsa1, Rajdeep Pooni2, Christy Sandborg1, Imelda Balboni1, Karen Wayman3 and Tzielan Lee4, 1Stanford University, Palo Alto, CA, 2Stanford Children's Health, Palo Alto, CA, 3Stanford Children’s Health, Palo Alto, CA, 4Stanford University School of Medicine, Palo Alto, CA

    Background/Purpose: Health information transparency enabled by the widespread adoption of patient portals and open notes has truly transformed the way healthcare is delivered. However, broader…
  • Abstract Number: 1894 • ACR Convergence 2021

    Natural Language Processing Tool for Extraction of Patient-Reported Outcomes from a National Multi-Electronic Health Records Registry

    Marie Humbert-Droz1, Zara Izadi2, Gabriela Schmajuk2, Milena Gianfrancesco2, Jinoos Yazdany2 and Suzanne Tamang3, 1Stanford University, Stanford, 2University of California San Francisco, San Francisco, CA, 3Stanford Center for Population Health Sciences, Redwood City, CA

    Background/Purpose: Patient reported outcomes (PROs) are increasingly used to track disease activity and facilitate shared decision making in patients with RA. Assessments of disease activity…
  • Abstract Number: 1924 • ACR Convergence 2021

    Patient Clustering Based on Multimorbidity Patterns Predicts Healthcare Utilization and Mortality in Rheumatoid Arthritis Within Independent Real-World Datasets

    Bryant England1, Yangyuna Yang1, Punyasha Roul1, Christian Haas2, Harlan Sayles1, Fang Yu1, Brian Sauer3, Joshua Baker4, Kaleb Michaud1, Jeffrey Curtis5 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Omaha, Omaha, NE, 3University of Utah, Salt Lake City, UT, 4University of Pennsylvania, Philadelphia, PA, 5Division of Clinical Immunology and Rheumatology, Department of Medicine, Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Rheumatoid arthritis (RA) leads to substantial healthcare utilization and premature mortality. Prior work has demonstrated that the overlapping presence of comorbid chronic conditions, termed…
  • Abstract Number: 0167 • ACR Convergence 2020

    Rheumatoid Arthritis Patient Phenotypes from a Digital Health Coaching Engagement Program

    Jonathan Patterson1, Kirby Magid2, Dhiren Patel3 and Matt Allison3, 1Pack Health, Birmingham, AL, 2University of North Carolina at Charlotte, Charlotte, 3Pack Health, Birmingham

    Background/Purpose: The goal of this study was to examine whether cluster analysis could be used to identify homogeneous subgroups of engagement in RA patients enrolled…
  • Abstract Number: 0257 • ACR Convergence 2020

    Application of Text Mining Methods to Identify Lupus Nephritis from Electronic Health Records

    Milena Gianfrancesco1, Suzanne Tamang2, Gabriela Schmajuk3 and Jinoos Yazdany4, 1University of California, San Francisco, San Francisco, CA, 2Stanford Center for Population Health Sciences, Redwood City, CA, 3University of California, San Francisco, Atherton, CA, 4UCSF, San Francisco, CA

    Background/Purpose: Lupus nephritis (LN) is a frequent complication of SLE and associated with higher morbidity and mortality. Accurate estimates of the prevalence of LN in…
  • Abstract Number: 0569 • ACR Convergence 2020

    Ability and Willingness to Utilize Telemedicine Among Rheumatology Patients – a Cross Sectional Survey

    Steve Kong1, Lilian Otalora Rojas2, Amnie Ashour3, Mathew Robinson1 and Neha Bhanusali1, 1University of Central Florida College of Medicine, Orlando, 2University of Central Florida HCA Healthcare GME, Orlando, 3Stony Brook University School of Medicine, New York

    Background/Purpose: Telemedicine (TM) is the delivery of health care services using information and communication technologies. TM presents unique opportunities and benefits specifically in rheumatology as…
  • Abstract Number: 0578 • ACR Convergence 2020

    Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics

    Rian Penford1, Angela Reith1, Elaine Wren1 and Kirsten Mackay1, 1Torbay and South Devon NHS Foundation Trust, Torquay, United Kingdom

    Background/Purpose: Until the COVID 19 crisis we initiated DMARD(s) and Biologic therapies using shared medical clinics. More than 30 patients could seen per week, with…
  • Abstract Number: 0589 • ACR Convergence 2020

    The Ideal Mhealth Application for Rheumatoid Arthritis: Qualitative Findings from Stakeholder Focus Groups

    Diederik De Cock1, Maryline Vandeputte2, Rani Van Melder2, Michael Doumen2, Delphine Bertrand1, Veerle Stouten1, Sofia Pazmino1, Rene Westhovens3 and Patrick Verschueren4, 1KU Leuven, Leuven, Belgium, 2KU Leuven, Leuven, 3University Hospitals Leuven, Belgium, Leuven, Belgium, 4University Hospital Leuven, Leuven, Belgium

    Background/Purpose: Early access to specialized rheumatological care is under increasing pressure. Many countries are currently confronted with a relative shortage of practicing rheumatologists, while recent…
  • Abstract Number: 0973 • ACR Convergence 2020

    Novel Network Tool Highlights Key Features Associated with Disease Pathotypes and Response to Treatment in Early Rheumatoid Arthritis

    Elisabetta Sciacca1, Anna Surace2, Myles Lewis1, Salvatore Alaimo3, Vito Latora4, Felice Rivellese1, Alfredo Pulvirenti3, Alfredo Ferro3 and Costantino Pitzalis5, 1Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, London, United Kingdom, 2Centre for Experimental Medicine and Rheumatology, Queen Mary University of London, Liverpool, United Kingdom, 3Bioinformatics Unit, Dept of Clinical and Experimental Medicine, University of Catania, Catania, Sicilia, Italy, 4School of Mathematical Sciences Queen Mary, University of London, London, United Kingdom, 5Queen Mary University of London, London, United Kingdom

    Background/Purpose: Biomedical research uses many statistical/bioinformatics tools to find genes or proteins differentially expressed between patient group of interest. However, biological elements are related to…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology